Table 2 Recruiting and not yet recruiting trials for FAP-specific PET for non-malignant indications on clinicaltrials.gov
Title | Estimated enrollment | Estimated Study completion Date | Indication | Tracer | Location | Key Interventions |
|---|---|---|---|---|---|---|
Characterizing Rheumatoid Arthritis With 68Ga-FAPI PET/CT | 100 patients | 10/2021 | Arthritis | Not specified | Peking Union Medical College Hospital | Patients who underwent FDG PET for suspected or confirmed untreated arthritis will receive and additional FAP-specific PET within two weeks |
Characterizing Inflammatory Bowel Disease With 68Ga-FAPI PET/CT | 100 patients | 10/2021 | Inflammatory bowel disease | Not specified | Peking Union Medical College Hospital | Patients who underwent FDG PET for suspected or confirmed untreated inflammatory bowel disease will receive and additional FAP-specific PET within two weeks |
Characterizing IgG4-RD With 68Ga-FAPI PET/CT | 100 patients | 10/2021 | IgG4-related disease | Not specified | Peking Union Medical College Hospital | Patients who underwent FDG PET for suspected or confirmed untreated IgG4-related disease will receive and additional FAP-specific PET within two weeks |
68Ga-FAPI PET/CT in Liver Fibrosis Patients (GFAPILF) | 50 patients | 12/2023 | Liver fibrosis | 68Ga -FAPI-04 | First Affiliated Hospital of Fujian Medical University | Patients with suspected newly diagnosed or previously treated liver fibrosis will receive FAP-specific PET, transient elastography and blood testing |
18F-FDG and 68Ga -FAPI PET/CT in Crohn's Disease | 30 patients | 09/2021 | Crohn’s disease | Not specified | Peking Union Medical College Hospital | Patients with Crohn’s disease with proofs of intestine stricture by other modalities (MRI/CT/ultrasound/endoscopy) will undergo FDG and FAP-specific PET within two days In patients with resection of the stenotic intestine, the extent of inflammation and fibrosis will be analyzed |